Royalty Pharma plc ($RPRX)
Filing Information
| Accession Number | 0001838139-26-000024 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 7, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
11,252
Total Value
$0.00
P&L
+inf% (+$509,395.96)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Research&Investments | Class A Ordinary Shares | โ | Aug 5, 2026 | Grant/Award | 8,252 | $0.00 | $0.00 | 8,252 | Direct | โ | View Details | |
EVP, Research&Investments | LP interests in RPI US Partners 2019, LP | Derivative | Aug 7, 2026 | Gift | 3,000 | $0.00 | $0.00 | 244,412 | Indirect | By Sandy Lamm LLC | View Details |